Please wait a minute...
 Home  About the Journal Editorial Board Aims & Scope Peer Review Policy Subscription Contact us
Early Edition  //  Current Issue  //  Open Special Issues  //  Archives  //  Most Read  //  Most Downloaded  //  Most Cited
Aging and disease    2018, Vol. 9 Issue (4) : 566-577     DOI: 10.14336/AD.2017.1001
Orginal Article |
Effect of Aging and Glucagon-like Peptide 2 on Intestinal Microbiota in SD Rats
Wu Jiayu1, Ren Weiying1, Li Li2, Luo Man1, Xu Kan1, Shen Jiping1, Wang Jia1, Chang Guilin1, Lu Yi1, Qi Yiming2, Xu Binger1, He Yuting1, Hu Yu1,*
1Department of Geriatrics, Zhongshan Hospital, Fudan University, Shanghai 200032, China
2Department of Internal Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China
Download: PDF(1171 KB)   HTML
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks    

Recent research suggests that intestinal microbiota affect the aging process. Glucagon-like peptide 2 (GLP-2), a growth factor found in the intestinal mucosal epithelium, reduces intestinal permeability and affects intestinal microbiota. The relationship between aging, GLP-2, and intestinal microbiota are still not well understood. The current study examined the influence of aging and GLP-2 on the intestinal microbiota of rats. Twelve 3-month old male SD rats were randomly divided into two groups: a young control group (group C) and a young GLP-2 treatment group (group G). Twelve 26-month old male SD rats were randomly divided into two groups: an aged control group (group L) and an aged GLP-2 treatment group (group T). GLP-2 was intraperitoneally injected into rats from group G and group T for 14 days. Plasma GLP-2 concentration was evaluated by ELISA tests. Fresh intestinal stool samples were collected from each group and total fecal bacterial genomic DNA was extracted from the associated rats. The bacterial composition of fecal samples was analyzed by Miseq high-throughput sequencing and comparison with SRA databases. Overall, the diversity of intestinal microbiota significantly decreases with age in SD rats, while GLP-2 has no significant effect on the diversity of intestinal microbiota. Upon aging, there is a reduction in probiotic bacteria and a concomitant increase in pathogenic bacteria in rats. Treatment with GLP-2 results in a significant reduction in the prevalence of pathogenic bacterial genera and an increase in some potential benefit bacteria in aged rats. In addition, treatment with GLP-2 results in an increase in several probiotics and a reduction in the prevalence of pathogenic bacterial genera in young rats.

Keywords aging      GLP-2      intestinal microbiota      high-throughput sequencing     
Corresponding Authors: Hu Yu   
About author:

These authors contributed equally to this work.

Issue Date: 01 August 2018
E-mail this article
E-mail Alert
Articles by authors
Wu Jiayu
Ren Weiying
Li Li
Luo Man
Xu Kan
Shen Jiping
Wang Jia
Chang Guilin
Lu Yi
Qi Yiming
Xu Binger
He Yuting
Hu Yu
Cite this article:   
Wu Jiayu,Ren Weiying,Li Li, et al. Effect of Aging and Glucagon-like Peptide 2 on Intestinal Microbiota in SD Rats[J]. Aging and disease, 2018, 9(4): 566-577.
URL:     OR
GroupNo. of readsNo. of OTUsRichness estimatorα-Diversity index

Ace95% CIChao95% CICoverageShannon
Group C699272124413393.1-431.9415384.9-445.80.98934.40
Group G723902111400386.5-414.1406392.3-419.70.99094.55
Group L780311848367345.3-388.4372336.0-408.00.99163.90
Group T716381912371339.0-402.7385345.7-424.30.99103.82
Table 1  Diversity estimation of the intestinal microbiota in SD rats.
Figure 1  Comparison of diversity indices, Venn diagram, rarefaction curve, PCoA, and plasma concentration of GLP-2 among the 4 groups

Comparison of diversity indices including the Shannon Curve (A) and Shannon Index (B). (C) Venn diagram illustrating overlap between the 4 groups. (D) Rarefaction curve. (E) PCoA was analyzed by unweighted Unifrac. (F) Plasma concentration of GLP-2 among the 4 groups. C denotes group C; G denotes group G; L denotes group L; T denotes group T; young denotes group C and group G; old denotes group L and group T; treat denotes treatment with GLP-2; * denotes P<0.05.

Figure 2  Relative abundance at the phylum level and the genus level in fecal microbiota

(A) Relative abundance at the phylum level in fecal microbiota. (B) Relative abundance at the genus level in fecal microbiota.

Group C0.4574876170.457818830.0370454670.0298362420.000116522
Group G0.4222286420.4654884350.0438704020.0478687830.001192522
Group L0.5593298830.3896321820.0205497550.0000000000.015300716
Group T0.4708080050.4821633850.0277434440.00049830.007512288
Table 2  The relative abundance of microbial phyla in the microbiota of Groups C, G, L and T.
Figure 3  Comparison relative abundance of microbiota at the phylum level among the 4 groups

Relative abundance (at the phylum level) of Bacteroidetes (A), Firmicutes (B), Proteobacteria (C), Verrucomicrobia (D), and Spirochaetae (E) among the 4 groups. C denotes group C; G denotes group G; L denotes group L; T denotes group T; * denotes P<0.05.

SequenceGenusAbundance in Group C (%)Abundance in Group L (%)Trends in Group L
1Alistipes *0.0042280.000141
2Allobaculum *0.0208270.000000
3Anaerovibrio *0.0000000.003652
4Bifidobacterium *0.0005740.000000
5Christensenellaceae_uncultured *0.0085200.001827
6Clostridium_sensu_stricto_1 *0.0077290.000410
7Corynebacterium *0.0057290.000000
8Helicobacter *0.0100860.002609
9Jeotgalicoccus *0.0039660.000000
10Marvinbryantia *0.0066850.000059
11Paraprevotella *0.0016150.000000
12Parasutterella *0.0130600.000063
13Peptococcaceae_uncultured *0.0023930.000247
14Prevotellaceae_unclassified *0.0683510.355279
15Psychrobacter *0.0063870.000000
16RC9_gut_group *0.0000000.005918
17Ruminococcaceae_uncultured *0.1148760.060653
18S24-7_norank *0.2449960.029386
19Streptococcus *0.0011720.003484
20Thalassospira *0.0003410.001554
21Treponema *0.0001170.015301
22p-2534-18B5_gut_group_norank *0.0000000.007516
Table 3  The relative abundance of microbial genera in the microbiota of Group C and Group L.
Figure 4  Comparison relative abundance of microbiota at the genus level among the 4 groups

Relative abundance (at the genus level) of Anaerovibrio (A), Desulfovibrio (B), Helicobacter (C), Intestinimonas (D), Oscillibacter (E), Parasutterella (F), Prevotella (G), Psychrobacter (H), and Treponema (I) among the 4 groups. C denotes group C; G denotes group G; L denotes group L; T denotes group T; * denotes P<0.05.

Figure 5  The linear correlation between plasma concentrations of GLP-2 and relative abundance of microbiota

The linear correlation between plasma concentrations of GLP-2 and relative abundance of Spirochaetae (A), Intestinimonas (B), Desulfovibrio (C), Treponema (D).

[1] Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett C, Knight R, Gordon JI (2007). The human microbiome project: exploring the microbial part of ourselves in a changing world. Nature, 449:804-810.
[2] Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R (2009). Bacterial community variation in human body habitats across space and time. Science, 326:1694-1697.
[3] Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. (2010). A human gut microbial gene catalogue established by metagenomic sequencing. Nature, 464:59-65.
[4] Jeremy KN, Elaine H, James K, Remy B, Glenn G, Wei J, et al. (2012). Host-gut microbiota metabolic interactions. Science, 336:1262-1267.
[5] Biagi E, Nylund L, Candela M, Ostan R, Bucci L, Pini E, et al. (2010). Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One, 5:e10667.
[6] Lees H, Swann J, Poucher SM, Nicholson JK, Holmes E, Wilson ID, et al. (2014). Age and microenvironment outweigh genetic influence on the Zucker rat microbiome. PLoS One, 9:e100916.
[7] Ouwehand AC, Bergsma N, Parhiala R, Lahtinen S, Gueimonde M, Finne-Soveri H, et al. (2008). Bifidobacterium microbiota and parameters of immune function in elderly subjects. FEMS Immunol Med Microbiol, 53:18-25.
[8] Jeong JJ, Kim KA, Jang SE, Woo JY, Han MJ, Kim DH (2015). Orally administrated Lactobacillus pentosus var. plantarum C29 ameliorates age-dependent colitis by inhibiting the nuclear factor-kappa B signaling pathway via the regulation of lipopolysaccharide production by gut microbiota. PLoS one, 10:e0116533.
[9] Chen X, Zhao HX, Fu XS, Li CP, Zhong XL (2012). Glucagonlike peptide 2 protects intestinal barrier in severe acute pancreatitis through regulating intestinal epithelial cell proliferation and apoptosis. Pancreas, 41:1080-1085.
[10] Litvak DA, Hellmich MR, Evers BM, Banker NA, Townsend CM Jr (1998). Glucagon-like peptide 2 is a potent growth factor for small intestine and colon. J Gastrointest Surg, 2:146-150.
[11] Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, et al. (2009). Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2- driven improvement of gut permeability. Gut, 58:1091-1103.
[12] Bomhof MR, Saha DC, Reid DT, Paul HA, Reimer RA (2014). Combined effects of oligofructose and Bifidobacterium animalis on gut microbiota and glycemia in obese rats. Obesity (Silver Spring), 22:763-771.
[13] Russo F, Linsalata M, Clemente C, Chiloiro M, Orlando A, Marconi E, et al. (2012). Inulin-enriched pasta improves intestinal permeability and modifies the circulating levels of zonulin and glucagon-like peptide 2 in healthy young volunteers. Nutr Res, 32:940-946.
[14] Simon C, Strassburger K, Nowotny B, Kolb H, Nowotny P, Burkart V, et al. (2015). Intake of Lactobacillus reuteri improves incretin and insulin secretion in glucose-tolerant humans: a proof of concept. Diabetes Care, 38:1827-1834.
[15] Lozupone C, Knight R (2015). UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol, 71: 8228-8235.
[16] Zwielehner J, Liszt K, Handschur M, Lassl C, Lapin A, Haslberger AG (2009). Combined PCR-DGGE fingerprinting and quantitative-PCR indicates shifts in fecal population sizes and diversity of Bacteroides, bifidobacteria and Clostridium cluster IV in institutionalized elderly. Experimen Geronto, 44:440-446.
[17] Distrutii E, Reilly JA, McDonald C, Cipriani S, Renga B, Lynch MA, et al. (2014). Modulation of intestinal microbiota by the probiotic VSL#3 resets brain gene expression and ameliorates the age-related deficit in LTP. PLoS one, 9:e106503.
[18] Guigoz Y, Doré J, Schiffrin J (2008). The inflammatory status of old age can be nurtured from the intestinal environment. Curr Opin Clin Nutr Metab Care, 11:13-20.
[19] Schiffrin EJ, Morley JE, Donnet-Hughes A, Guigoz Y (2009). The inflammatory status of the elderly: the intestinal contribution. Mutat Res, 690:50-56.
[20] Biagi E, Candela M, Turroni S, Garagnani P, Franceschi C, Brigidi P (2013). Ageing and gut microbes: Perspectives for health maintenance and longevity. Pharmacological Research, 69:11-20.
[21] Drozdowski L, Thomson AB (2006). Aging and the intestine. World J Gastroenterol, 12:7578-84.
[22] McWeeney EJ (1905). Spirochaetae in syphilis. Br Med J, 1:1262-1263.
[23] Bartůnĕk P, Gorican K, Veiser T, Taborsky M, Hulínská D (2007). Significance of Borrelia infection in development of dilated cardiomypathy (a pilot study). Prague Med Rep, 108:339-347.
[24] Dapeci A, Zapletal L (1972). Quantitative changes of spirochaetae in ulcerative gingivitis after general therapy with penicillin and after local treatment with hydrogen peroxide. Cesk Stomatol, 72:96-101.
[25] Rimbara E, Mori S, Kim H, Matsui M, Suzuki S, Takahashi S, et al. (2013). Helicobacter cinaedi and Helicobacter fennelliae transmission in a hospital from 2008 to 2012. J Clin Microbiol, 51:2439-2442.
[26] Prins RA, Lankhorst A, van der Meer P, Van Nevel CJ (1975). Some characteristics of Anaerovibrio lipolytica a rumen lipolytic organism. Antonie Van Leeuwenhoek, 41:1-11.
[1] Tingting Sui,Di Liu,Tingjun Liu,Jichao Deng,Mao Chen,Yuanyuan Xu,Yuning Song,Hongsheng Ouyang,Liangxue Lai,Zhanjun Li. LMNA-mutated Rabbits: A Model of Premature Aging Syndrome with Muscular Dystrophy and Dilated Cardiomyopathy[J]. Aging and disease, 2019, 10(1): 102-115.
[2] Dong Liu,Liqun Xu,Xiaoyan Zhang,Changhong Shi,Shubin Qiao,Zhiqiang Ma,Jiansong Yuan. Snapshot: Implications for mTOR in Aging-related Ischemia/Reperfusion Injury[J]. Aging and disease, 2019, 10(1): 116-133.
[3] Wanying Duan, Yuehua Pu, Haiyan Liu, Jing Jing, Yuesong Pan, Xinying Zou, Yilong Wang, Xingquan Zhao, Chunxue Wang, Yongjun Wang, Ka Sing Lawrence Wong, Ling Wei, Liping Liu, . Association between Leukoaraiosis and Symptomatic Intracranial Large Artery Stenoses and Occlusions: the Chinese Intracranial Atherosclerosis (CICAS) Study[J]. Aging and disease, 2018, 9(6): 1074-1083.
[4] Calvin Pak-Wing Cheng, Sheung-Tak Cheng, Cindy Woon-Chi Tam, Wai-Chi Chan, Winnie Chiu-Wing Chu, Linda Chiu-Wa Lam. Relationship between Cortical Thickness and Neuropsychological Performance in Normal Older Adults and Those with Mild Cognitive Impairment[J]. Aging and disease, 2018, 9(6): 1020-1030.
[5] Yu-Wen Huang, Ming-Fu Chiang, Che-Sheng Ho, Pi-Lien Hung, Mei-Hsin Hsu, Tsung-Han Lee, Lichieh Julie Chu, Hsuan Liu, Petrus Tang, Wailap Victor Ng, Dar-Shong Lin. A Transcriptome Study of Progeroid Neurocutaneous Syndrome Reveals POSTN As a New Element in Proline Metabolic Disorder[J]. Aging and disease, 2018, 9(6): 1043-1057.
[6] Manuel Scimeca, Federica Centofanti, Monica Celi, Elena Gasbarra, Giuseppe Novelli, Annalisa Botta, Umberto Tarantino. Vitamin D Receptor in Muscle Atrophy of Elderly Patients: A Key Element of Osteoporosis-Sarcopenia Connection[J]. Aging and disease, 2018, 9(6): 952-964.
[7] Charlene Greenwood, John Clement, Anthony Dicken, Paul Evans, Iain Lyburn, Richard M. Martin, Nick Stone, Peter Zioupos, Keith Rogers. Age-Related Changes in Femoral Head Trabecular Microarchitecture[J]. Aging and disease, 2018, 9(6): 976-987.
[8] Ashok K. Shetty, Maheedhar Kodali, Raghavendra Upadhya, Leelavathi N. Madhu. Emerging Anti-Aging Strategies - Scientific Basis and Efficacy[J]. Aging and disease, 2018, 9(6): 1165-1184.
[9] Ze Teng, Aibo Wang, Peng Wang, Rui Wang, Wei Wang, Hongbin Han. The Effect of Aquaporin-4 Knockout on Interstitial Fluid Flow and the Structure of the Extracellular Space in the Deep Brain[J]. Aging and disease, 2018, 9(5): 808-816.
[10] Stefano Rizza, Marina Cardellini, Alessio Farcomeni, Pasquale Morabito, Daniele Romanello, Giovanni Di Cola, Maria Paola Canale, Massimo Federici. Low Molecular Weight Adiponectin Increases the Mortality Risk in Very Old Patients[J]. Aging and disease, 2018, 9(5): 946-951.
[11] Stefanie Hardt, Lucie Valek, Jinyang Zeng-Brouwers, Annett Wilken-Schmitz, Liliana Schaefer, Irmgard Tegeder. Progranulin Deficient Mice Develop Nephrogenic Diabetes Insipidus[J]. Aging and disease, 2018, 9(5): 817-830.
[12] Yong-Fei Zhao, Qiong Zhang, Jian-Feng Zhang, Zhi-Yin Lou, Hen-Bing Zu, Zi-Gao Wang, Wei-Cheng Zeng, Kai Yao, Bao-Guo Xiao. The Synergy of Aging and LPS Exposure in a Mouse Model of Parkinson’s Disease[J]. Aging and disease, 2018, 9(5): 785-797.
[13] Diano F. Marrone, Elham Satvat, Anuj Patel. Age-related Deficits in Recognition Memory are Protocol-Dependent[J]. Aging and disease, 2018, 9(5): 798-807.
[14] Maxime Fournet, Frederic Bonte, Alexis Desmouliere. Glycation Damage: A Possible Hub for Major Pathophysiological Disorders and Aging[J]. Aging and disease, 2018, 9(5): 880-900.
[15] Feng Tang,Meng-Hao Pan,Yujie Lu,Xiang Wan,Yu Zhang,Shao-Chen Sun. Involvement of Kif4a in Spindle Formation and Chromosome Segregation in Mouse Oocytes[J]. A&D, 2018, 9(4): 623-633.
Full text



Copyright © 2014 Aging and Disease, All Rights Reserved.
Address: Aging and Disease Editorial Office 3400 Camp Bowie Boulevard Fort Worth, TX76106 USA
Fax: (817) 735-0408 E-mail:
Powered by Beijing Magtech Co. Ltd